Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. FULC
FULC logo

FULC News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

FULC News

Fulcrum Discontinues pociredir Development, Shares Plunge 49%

17h agostocktwits

Biotech Stocks Show Strong Pre-Market Moves

2h agoNASDAQ.COM

Fulcrum Therapeutics Abandons Sickle-Cell Drug Development Amid FDA Concerns

4h agoNewsfilter

Fulcrum Therapeutics Halts pociredir Development Amid FDA Safety Concerns

4h agoseekingalpha

Fulcrum Discontinues Pociredir Program Amid FDA Concerns

8h agoNASDAQ.COM

Fulcrum Therapeutics Grants Stock Options to New Employees

May 08 2026Newsfilter

Fulcrum (FULC) Q1 2026 Earnings Transcript

Apr 27 2026NASDAQ.COM

Fulcrum Therapeutics Q1 Earnings Beat Expectations

Apr 27 2026seekingalpha

FULC Events

06/02 09:00
S&P 500 Futures Modestly Lower, HPE Shares Up 27%
Stock futures are modestly lower this morning after the S&P 500, Nasdaq, and Dow all closed at record highs on Monday. Investors are seemingly taking a cautious stance ahead of this week's labor-market data and additional comments from Federal Reserve officials.The market received another boost from strong technology-related news. Hewlett Packard Enterprise surged in premarket trading after raising financial targets, while AI-linked names such as Marvell and Nvidia also attracted buying interest. Enthusiasm surrounding data centers, AI infrastructure, and enterprise spending continues to provide the primary source of market leadership.Bond yields remain elevated but relatively stable. The 10-year Treasury yield is hovering around the mid-4.4% range. Investors are watching whether upcoming economic data can support the soft-landing narrative without reigniting inflation fears. The JOLTS job openings report is also in focus.In pre-market trading, S&P 500 futures fell 0.17%, Nasdaq futures fell 0.03% and Dow futures fell 0.49%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Marvellup 18% after NvidiaCEO Jensen Huang said at Computex Week in Taipei that the company is set to be the "next trillion-dollar company"Aveannaup 9% after raising its full-year outlook following completion of the acquisition of Family First HoldingMicrochipup 8% after FY26 data center solution revenue pre-announcementUP AFTER EARNINGS -HPEup 27%Citi Trendsup 10%Signet Jewelersup 7%Dollar Generalup 4%Donaldsonup 2%DOWN AFTER EARNINGS -Odditydown 19%Credo Technologydown 3%LOWER -Fulcrum Therapeuticsdown 51% after announcing the discontinuation of its pociredir program for the treatment of sickle cell disease and the initiation of a review of strategic alternativesPhilip Morrisdown 1% after cutting its full-year EPS view

FULC Monitor News

Fulcrum Therapeutics Stock Surges After Positive Trial Results

Dec 08 2025

FULC Earnings Analysis

No Data

No Data

People Also Watch